A detailed history of Mai Capital Management transactions in Dexcom Inc stock. As of the latest transaction made, Mai Capital Management holds 1,383 shares of DXCM stock, worth $124,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,383
Holding current value
$124,027
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$65.68 - $81.01 $90,835 - $112,036
1,383 New
1,383 $107,000
Q2 2024

Aug 12, 2024

BUY
$110.31 - $140.45 $18,532 - $23,595
168 Added 5.45%
3,252 $368,000
Q1 2024

May 08, 2024

BUY
$114.22 - $140.1 $98,457 - $120,766
862 Added 38.79%
3,084 $427,000
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $167,738 - $275,883
2,222 New
2,222 $275,000
Q2 2022

Jul 19, 2022

SELL
$67.99 - $132.89 $29,507 - $57,674
-434 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$94.08 - $130.2 $2,446 - $3,385
-26 Reduced 5.65%
434 $222,000
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $2,467 - $3,093
19 Added 4.31%
460 $247,000
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $6,295 - $8,447
-59 Reduced 11.8%
441 $241,000
Q2 2021

Jul 19, 2021

BUY
$80.99 - $107.93 $40,495 - $53,965
500 New
500 $214,000
Q3 2020

Oct 26, 2020

SELL
$95.51 - $112.95 $56,828 - $67,205
-595 Closed
0 $0
Q2 2020

Jul 27, 2020

SELL
$62.68 - $105.34 $10,592 - $17,802
-169 Reduced 22.12%
595 $241,000
Q1 2020

Apr 16, 2020

SELL
$47.79 - $75.63 $7,598 - $12,025
-159 Reduced 17.23%
764 $206,000
Q4 2019

Feb 03, 2020

BUY
$36.62 - $57.29 $33,800 - $52,878
923 New
923 $202,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.